Trials / Withdrawn

WithdrawnNCT00335101

Renal Effects of Three Iodinated Contrast Media (CM) in Patients at Risk Undergoing Coronary Angiography

Status: Withdrawn
Phase: Phase 4
Study type: Interventional
Enrollment: 0 (actual)

Sponsor: GE Healthcare · Industry
Sex: All
Age: 18 Years
Healthy volunteers: Not accepted

Summary

The study is to evaluate and compare the effects on kidney function of three iodinated contrast media (CM) in patients at risk of kidney damage evaluating serum creatinine (Scr) concentrations up to three days after CM administration.

Conditions

Coronary Artery Disease (CAD)
Renal Impairment
Diabetes Mellitus

Interventions

Type	Name	Description
DRUG	Iodixanol, Ioversol, Iopromide

Timeline

Start date: 2006-06-01
First posted: 2006-06-08
Last updated: 2019-04-29

Locations

2 sites across 2 countries: United States, Germany

Source: ClinicalTrials.gov record NCT00335101. Inclusion in this directory is not an endorsement.